IP Library Granted Patent US 7,399,466
Granted Patent B2
US 7,399,466 · App. 10/362,259 · Granted Jul 15, 2008

Method and compositions for promoting osteogenesis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,399,466
App. No.
10/362,259
Granted
Jul 15, 2008
Kind
B2
Abstract

The object of the present invention is to increase PHEX activity to improve the osteogenic process in a mammal where this process has been diminished due to pathology or a condition that require osteogenesis. Osteocalcin is an endogenous inhibitor of the PHEX activity. Therefore, the identification of a substance capable of potentiating PHEX activity by preventing the inhibitory action of endogenous inhibitors will improve osteogenesis. Since PHEX is generally associated with the growth plane of bone or teeth and the absence of osteocalcin is associated with increased bone mass, potentiation of PHEX activity can promote bone growth. Increased PHEX activity can also be obtained by administration of the enzyme itself.

Claims (25)

1. A method of treating a bone-related disorder requiring osteogenesis in a mammal, or treating a condition requiring osteogenesis in a mammal, comprising administering an effective amount of a soluble Phosphate Regulating Gene With Homologies To Endopeptidases On The X Chromosome protein (secPHEX) that comprises the sequence of amino acids as set forth in SEQ ID NO:11.

2. The method as recited in claim 1 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 and a cleavage-competent signal sequence that is substituted for the wild-type signal peptide/membrane anchor domain of a PHEX protein.

3. The method as recited in claim 1 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 fused at its amino terminus to the amino acid sequence set forth in SEQ ID NO:3.

4. The method as defined in claim 1 , wherein said bone-related disorder requiring osteogenesis is selected from the group consisting of osteopenia, osteoporosis, rickets, and X-linked hypophosphatemic rickets (XLH), and wherein said condition requiring osteogenesis is an orthopedic intervention and or a dental intervention.

5. The method as recited in claim 4 , wherein said bone-related disorder is XLH.

6. The method as recited in claim 5 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 and a cleavage-competent signal sequence that is substituted for the wild-type signal peptide/membrane anchor domain of a PHEX protein.

7. The method as recited in claim 5 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 fused at its amino terminus to the amino acid sequence set forth in SEQ ID NO:3.

8. A composition for treating a bone-related disorder requiring osteogenesis in a mammal, or treating a condition requiring osteogenesis in a mammal comprising an effective amount of a soluble Phosphate Regulating Gene With Homologies To Endopeptidases On The X Chromosome protein (secPHEX) and a pharmaceutically-acceptable carrier, wherein the secPHEX protein comprises the sequence of amino acids as set forth in SEQ ID NO:11.

9. The composition as recited in claim 8 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 and a cleavage-competent signal sequence that is substituted for the wild-type signal peptide/membrane anchor domain of a PHEX protein.

10. The composition as recited in claim 8 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 fused at its amino terminus to the amino acid sequence set forth in SEQ ID NO:3.

11. An orthopedic implant comprising a soluble Phosphate Regulating Gene With Homologies To Endopeptidases On The X Chromosome protein (secPHEX) protein that comprises the sequence of amino acids as set forth in SEQ ID NO:11.

12. The orthopedic implant as recited in claim 11 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 and a cleavage-competent signal sequence that is substituted for the wild-type signal peptide/membrane anchor domain of a PHEX protein.

13. The orthopedic implant as recited in claim 11 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 fused at its amino terminus to the amino acid sequence set forth in SEQ ID NO:3.

14. A dental prosthesis comprising a soluble Phosphate Regulating Gene With Homologies To Endopeptidases On The X Chromosome protein (secPHEX) protein that comprises the sequence of amino acids as set forth in SEQ ID NO:11.

15. The dental prosthesis as recited in claim 14 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 and a cleavage-competent signal sequence that is substituted for the wild-type signal peptide/membrane anchor domain of a PHEX protein.

16. The dental prosthesis as recited in claim 14 , wherein the secPHEX protein is obtained by the recombinant expression within an isolated host cell of a vector comprising a nucleotide sequence encoding a fusion polypeptide comprising a secPHEX protein having the amino acid sequence set forth in SEQ ID NO:11 fused at its amino terminus to the amino acid sequence set forth in SEQ ID NO:3.

17. A method of producing a soluble Phosphate Regulating Gene With Homologies To Endopeptidases On The X Chromosome protein (secPHEX) comprising expressing an in frame fusion of a nucleotide sequence encoding the amino acid sequence from position 1 through position 63 of Neprilysin-Like peptidase (NL1) as set forth in SEQ ID NO:9 with a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:11.

18. A vector comprising an in frame fusion of a nucleotide sequence encoding the amino acid sequence from position 1 through position 63 of Neprilysin-Like peptidase (NL1) as set forth in SEQ ID NO:9 with a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:11.

19. A method of expressing a soluble Phosphate Regulating Gene With Homologies To Endopeptidases On The X Chromosome protein (secPHEX) in an isolated host cell comprising:

(i) providing an expression vector comprising an in frame fusion of a nucleotide sequence encoding the amino acid sequence from position 1 through position 63 of Neprilysin-Like peptidase (NL1) set forth in SEQ ID NO:9 with a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:11;

(ii) introducing the vector into an isolated host cell; and

(iii) maintaining the isolated host cell under conditions permitting expression of secPHEX protein in the cell.

20. A method of separating a soluble Phosphate Regulating Gene With Homologies To Endopeptidases On The X Chromosome protein (secPHEX) from other components in a solution by applying the solution to a hydrophobic chromatographic column and removing those fractions comprising the secPHEX protein, wherein the secPHEX protein comprises the sequence of amino acids as set forth in SEQ ID NO:11, thereby separating the secPHEX protein from other components of the solution.

21. A method of separating a soluble Phosphate Regulating Gene With Homologies To Endopeptidases On The X Chromosome protein (secPHEX) from other components in a solution by applying the solution to an ion-exchange chromatographic column and removing those fractions comprising the secPHEX protein, wherein the secPHEX protein comprises the sequence of amino acids as set forth in SEQ ID NO:11, thereby separating the secPHEX protein from other components of the solution. fused at its amino terminus to the amino acid sequence set forth in SEQ ID NO:3.

22. A secPHEX fusion polypeptide encoded by the vector of claim 18 .

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2016
From: ALEXION PHARMA HOLDING
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 037600/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2013
From: ALEXION PHARMA INTERNATIONAL SARL
To: ALEXION HOLDING B.V.
Reel/Frame 030894/0591 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2013
From: ALEXION HOLDING B.V.
To: ALEXION PHARMA HOLDING
Reel/Frame 030894/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2013
From: ENOBIA CANADA LIMITED PARTNERSHIP
To: ALEXION PHARMA INTERNATIONAL SARL
Reel/Frame 029670/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2012
From: ENOBIA PHARMA INC.
To: ENOBIA CANADA LIMITED PARTNERSHIP
Reel/Frame 027752/0067 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SECOND ASSIGNOR PREVIOUSLY RECORDED ON REEL 016838 FRAME 0119. ASSIGNOR(S) HEREBY CONFIRMS THE SECOND ASSIGNOR IS TO BE REMOVED. Recorded Dec 2, 2005
From: BIOMEP, INC.
To: ENOBIA PHARMA INC.
Reel/Frame 016845/0041 →
CHANGE OF NAME Recorded Dec 1, 2005
From: BIOMEP INC.; ENOBIA PHARMA INC.
To: ENOBIA PHARMA INC.
Reel/Frame 016838/0119 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2003
From: BOILEAU, GUY
To: BIOMEP INC.
Reel/Frame 014639/0645 →